Table 5. Genotype combination in relation to disease severity.
IFNγ/IL10 genotypes | TBNA | PMN | PMD | PAD | DTB | LTB |
N | 188 | 19 | 63 | 29 | 20 | 47 |
TT/GG % | 2.13 | 10.53 | 1.59 | 6.9 | 0 | 4.2 |
chi2 | 6.66 | |||||
corrected p = | 0.01 | |||||
OR | 6.06 | |||||
(95% CI) | (1.30–28.07) | |||||
TT/AA % | 3.19 | 10.53 | 6.35 | 3.45 | 5 | 2.13 |
chi2 | 4.92 | |||||
corrected p = | 0.027 | |||||
OR | 3.99 | |||||
(95% CI) | (1.08–14.8) | |||||
TT/GA% | 7.98 | 21.05 | 17.46 | 0 | 10 | 12.8 |
chi2 | 6.82 | 4.4 | ||||
corrected p = | 0.009 | 0.036 | ||||
OR | 3.06 | 2.50 | ||||
(95% CI) | (1.08–7.28) | (1.04–6.1) | ||||
TA/GG % | 5.85 | 0 | 4.76 | 6.9 | 10 | 2.13 |
chi2 | ||||||
corrected p = | ||||||
OR (95% CI) | ||||||
TA/AA % | 5.32 | 10.53 | 6.35 | 6.9 | 0 | 4.2 |
chi2 | ||||||
corrected p = | ||||||
OR (95% CI) | ||||||
TA/GA % | 35.11 | 21.05 | 33.33 | 31.03 | 30 | 40.4 |
chi2 (p-value) | 4.86 | |||||
corrected p = | 0.028 | |||||
OR | 0.40 | |||||
(95% CI) | (0.26–0.93) | |||||
AA/GG % | 2.66 | 10.53 | 4.76 | 13.79 | 10 | 2.13 |
chi2 | 4.92 | 7.78 | 4.03 | |||
corrected p = | 0.027 | 0.005 | 0.045 | |||
OR | 3.99 | 5.26 | 3.59 | |||
(95% CI) | (1.08–14.79) | (1.46–18.9) | (0.96–13.47) | |||
AA/AA % | 8.51 | 0 | 3.17 | 13.79 | 15 | 2.13 |
chi2 | 4.71 | |||||
corrected p = | 0.03 | |||||
OR | 0.21 | |||||
(95% CI) | (0.04–0.98) | |||||
AA/GA % | 39.26 | 15.79 | 22.2 | 17.24 | 20 | 29.7 |
chi2 | 4.85 | 4.06 | ||||
corrected p = | 0.028 | 0.044 | ||||
OR | 0.45 | 0.50 | ||||
(95% CI) | (0.24–0.93) | (0.25–0.99) |